Backed By Biosimilars, Vaccines, Transdermals And Respiratory Drugs, India's Cadila Sets Sights On $3 Bil In Sales By 2015

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.